DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Point-of-Care Diagnostics Global Market - Forecast to 2023" report to their offering.
The point of care diagnostics global market is expected to grow at single digit CAGR to reach $26,331.1 million by 2023.
The Point of care diagnostics market is segmented based on their products, technology, prescription mode, sample types, end-users, and geography:
- The global POCD market by products is segmented into glucose monitoring kits, infectious diseases testing kits, coagulation monitoring kits, hematology testing kits, pregnancy and fertility testing kits, cardiometabolic testing kits, tumor/cancer markers, urinalysis kits, cholesterol testing kits, drugs-of-abuse testing kits and others.
- The glucose monitoring kits are further segmented into self-glucose monitoring and continuous glucose monitoring kits.
- The Infectious diseases kits are further divided into HIV testing kits, Hepatitis testing kits, Tropical diseases testing kits, tuberculosis testing kits, Healthcare-Associated infection testing kits, respiratory infections testing kits, and others.
- The coagulation monitoring testing kits are further segmented into Prothrombin Time(PT/INR) Testing Kits and Activated Clotting Time(ACT/APTT) Testing Kits.
- The Pregnancy and Fertility Testing Kits are further segmented into Pregnancy Testing Kits and Fertility Testing Kits.
- The Cardiometabolic Monitoring Kits further segmented into Cardiac Markers, Blood Gas/Electrolytes Testing Kits, HBA1C Testing Kits, and LIPID Testing Kits.
- By technology, the POCD market is divided into a biosensor,microfluidics/lab-on-a-chip technology, PCR technology, Immunochromatographic/lateral flow technology and others.
- Based on prescription mode, POCD market is segmented into prescription based tests and over the counter tests.
- By sample types, POCD market is divided into blood, urine, saliva and others.
- Based on end-users, POCD market is segmented into hospitals, home healthcare, clinics.
Key Topics Covered:
1 Executive Summary
3 Market Overview
4 Point of Care Diagnostics Global Market, by Products
5 Point of Care Diagnostics Market, by Technology
6 Point of Care Diagnostics Market, by Prescription Mode
7 Point of Care Diagnostics Market, by Sample Type
8 Point of Care Diagnostics Global Market, by End User
9 Regional Market Analysis
10 Company Developments
11 Major Companies
- Abaxis, Inc.,
- Abbott Laboratories, Inc.
- Beacon Biomedical
- Becton Dickinson and Company
- Biolight Life Sciences
- Biolytical Laboratories Inc.
- Enigma Diagnostics
- Enterix, Inc
- Epitope Diagnostics Inc,
- Erba Diagnostics Mannheim Gmbh
- Euromedix Poc NV/SA
- Exosomes Diagnostics
- F. Hoffmann-La Roche Ag
- Hemosure Inc.,
- Humor Diagnostica
- Insilixa, Inc
- Lipid Plus
- Mbio Diagnostics, Inc
- Medica Corporation
- Medmira Inc.
- Medtronic Plc
- Meridian Bioscience, Inc,
- Omnica Corporation
- Operon Biotech & Healthcare
- Ophthalmic Instrument Company
- Response Biomedical
- Siemens Ag
- Thermofisher Scientific, Inc.
- ZBX Corporation
For more information about this report visit http://www.researchandmarkets.com/research/4td2hq/pointofcare